← Browse by Condition
Medical Condition
refractory leukemia
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2, Phase 1
NCT07356154 Phase 1, Phase 2
Recruiting
A Study of Revumenib and Mezigdomide in People With Leukemia
Enrollment
52 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT05043571 Phase 1
Recruiting
CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia
Enrollment
20 pts
Location
Singapore
Sponsor
National University Hospital, ...